Please assess the completion status of the following clinical trial:

Trial Title: Nephropathy In Type 2 Diabetes and Cardio-renal Events

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* type 2 diabetic patients~* albumin extraction rate (AER= \>30 mg/die (micro- or macro-albuminuric ranges) in at least two determinations in the last six months~* diabetic retinopathy~* patients followed in the outpatients clinic for at least 12 months~Exclusion Criteria:~* type 1 diabetic patients~* \<40 years old

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Standard of Care (SoC) therapy (Type: ACTIVE_COMPARATOR): Control group patients will continue their SoC therapy. During the study such patients could receive all the therapeutic modifications according to the good medical practice of the specialist.
- Multifactorial Intensified therapy (Type: EXPERIMENTAL): An intensive multifactorial intervention according Scientific Guidelines is performed to achieve the goals for the following risk factors: hypertension, hyperglycaemia, lipids, anaemia.~In particular, new antihypertensive drugs will be added one by one until the achievement of blood pressure target (\<130/80 mmHg).

Based on this trial design, predict the completion outcome and termination type (if applicable).